[CYCC] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
05-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -21.15%
YoY- -14.12%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 150 0 277 -
PBT -9,000 -6,491 -3,182 -2,752 -2,370 -2,071 -3,249 18.49%
Tax -1,581 -1,197 -378 -449 -352 -200 -409 25.26%
NP -7,419 -5,294 -2,804 -2,303 -2,018 -1,871 -2,839 17.35%
Tax Rate - - - - - - - -
Total Cost 7,419 5,294 2,804 2,303 2,168 1,871 3,116 15.54%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 -47,711,417,389,824.74 0.00 -1,345.33 0.00 -1,024.91 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -8.87 -0.54 -0.57 -2.68 -2.96 -3.14 -13.34 -6.57%
EPS Diluted -8.87 -0.54 -0.57 -2.68 -2.96 -3.12 -13.34 -6.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.